2 terminated, 1 completed, 1 withdrawn. 2 Phase 1, 1 Early Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 1, Withdrawn 1 |
| Early Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow House Research Institute: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Feasibility Study of Auditory Brainstem Implant in Young Children Auditory brainstem implant - Bilateral Cochlear Aplasia, Bilateral Cochlear Nerve Deficiency | Phase 1 | Withdrawn | House Research Institute | 2013-10-01 | 2015-03-18 | |
| Intratympanic Injection for Autoimmune Inner Ear Disease Golimumab - Autoimmune Inner Ear Disease | Phase 1 / Phase 2 | Terminated | House Research Institute | 16 | 2012-03-01 | 2013-10-14 |
| Famvir for Treatment of Hearing in Unilateral Meniere's Disease Famciclovir, Placebo - Meniere's Disease | Phase 3 | Terminated | House Research Institute | 11 | 2011-12-01 | 2021-04-19 |
| Concentration and Activity of Lapatinib in Vestibular Schwannomas lapatinib - Vestibular Schwannoma, NF2 | Early Phase 1 | Completed | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 26 | 2009-06-01 | 2021-01-12 |
Hearing Loss (2) · Hearing Loss, Bilateral (1) · Meniere Disease (1) · Neurofibromatosis 2 (1) · Neuroma, Acoustic (1) · Tinnitus (1) · Vertigo (1)
Auditory Brain Stem Implants (1) · Famciclovir (1) · Lapatinib (1) · golimumab (1)
United States (2)
Jennifer Derebery, MD (2) · Eric Wilkinson, MD (1) · Jaishri O Blakeley, MD (1) · Laurie Eisenberg, PhD (1)